Risk Management


<< Back
Share
 Print Download

Giant Cell Arteritis Toolkit (2022)

Allegations of failure to diagnose are common in medical malpractice lawsuits against ophthalmologists. Some ophthalmic conditions, such as giant cell arteritis (GCA), have a short window for diagnosis and treatment. The patient then risks severe bilateral vision loss, and the treating ophthalmologist incurs liability exposure.

OMIC offers the following tools, developed by board member Ron Pelton, MD, to help ophthalmologists strengthen their diagnostic and patient management process for GCA:

Giant Cell Arteritis Checklist

·         Helps prompt questions to ask patients during the work-up, and track completion of key tests and consults.

GCA Pt Info Sheet with Consent-Refusal

·         Supports communication to patients of signs and symptoms to watch for and instructions for contacting the ophthalmologist. Includes a sample form to document the patient’s understanding of GCA in general and consent or refusal to proceed with treatment in general. 

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.

61864684